Search results
The Zacks Analyst Blog Highlights Apple, Mastercard, Amgen, Utah Medical Products and Bridger...
Zacks via Yahoo Finance· 12 hours agoIt expects strong sales growth of products like Tezspire, Evenity, Repatha, Prolia and Tavneos to...
What Your Symptoms Can Tell You About Your Rheumatoid Arthritis
Health.com· 5 days agoRheumatoid arthritis (RA) is an autoimmune disorder that causes inflammation, pain, and stiffness in...
What to know about biologics for Crohn's disease
Medical News Today· 1 day agoCrohn’s disease biologics are medications created using components of living organisms. Crohn’s disease (CD), along with ulcerative colitis, is one of...
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 4 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 5 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...
Maryland Drug Board Advances Ozempic, Other Cost Reviews (1)
Bloomberg Law· 4 days agoBlockbuster diabetes drugs Ozempic and Trulicity will be included in the Maryland prescription drug board’s first cost review, a monthslong process that will help the panel determine whether ...
Biogen Inc. (NASDAQ:BIIB) Shares Sold by Dai ichi Life Insurance Company Ltd
ETF DAILY NEWS· 15 hours agoDai ichi Life Insurance Company Ltd lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 47.1% during the fourth quarter, according to its most recent disclosure with ...
6 Safe Blue Chip Dividend Stocks That Yield More Than Treasury Bonds
247wallst.com· 5 days agoSince 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital ...
Needham & Company LLC Reiterates “Buy” Rating for Biogen (NASDAQ:BIIB)
ETF DAILY NEWS· 22 hours agoBiogen (NASDAQ:BIIB – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report issued on Wednesday, Benzinga reports. Needham & Company LLC’s price objective ...